Company Filing History:
1 out of 5 
1 out of 49 
Years Active: 2014
Title: Hannes Braun - Innovator in Peptide-Mimetic Compounds
Introduction
Hannes Braun is a notable inventor based in Hofheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide-mimetic compounds. His work focuses on the inhibition of proteasomes and the induction of apoptosis in tumor cells, which has important implications for cancer treatment.
Latest Patents
Hannes Braun holds a patent for "Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors." This invention relates to peptide-mimetic compounds that can inhibit proteasomes and induce apoptosis in tumor cells. Furthermore, it encompasses pharmaceutical compositions that utilize these compounds for treating diseases, especially cancer and neurodegenerative disorders.
Career Highlights
Throughout his career, Hannes Braun has worked with prestigious institutions such as Technische Universität and Charité-Universitätsmedizin Berlin. His research has contributed to advancements in therapeutic strategies for complex diseases, showcasing his expertise in the field.
Collaborations
Hannes has collaborated with notable colleagues, including Boris Schmidt and Sumaira Umbreen. These partnerships have enhanced his research and development efforts, leading to innovative solutions in the medical field.
Conclusion
Hannes Braun's work in peptide-mimetic compounds represents a significant advancement in the fight against cancer and neurodegenerative diseases. His contributions to the field highlight the importance of innovation in medical research and the potential for new treatments.